Dr.  Defu Zeng obtained his MD from Fujian Medical University and postdoctoral training in transplantation immunology at Stanford University School of Medicine. Dr. Zeng has been a full professor of Immunology/Hematopoietic Cell Transplantation at the Beckman Research Institute, City of Hope National Medical Center in California since 2013. Dr. Zeng has become an internationally well-recognized leading scientist in the preclinical field of GVHD pathogenesis, prevention and therapy. Dr. Zeng is also a pioneer in the field of induction of mixed chimerism as a curative therapy for hereditary hematological disorders and autoimmune diseases. Dr. Zeng’s studies are well funded with two NIH R01 and CIRM clinical trial grants.

Dr. Zeng has >75 high impact publications in Science translational Medicine, Nature communications, JCI, JEM, PNAS, Blood. He has written commentaries for JCI, PNAS and blood, as well as a chapter “Mechanisms of Immune Tolerance” in Thomas Hematopoietic Cell Transplantation, Edition V (2016). Dr. Zeng had been a standing member of NIH study section of transplantation, tolerance, and tumor (TTT) and is now an Ad Hoc reviewer for many NIH study sections. Dr. Zeng also participates in international grant review service in China and Hong Kong.